Bills Advancing In US Congress Would Hasten FDA Reviews Of Non-Opioid Medtech Alternatives

The Senate Health, Education, Labor and Pensions (HELP) Committee and House Energy and Commerce Health Subcommittee each passed bills this week to expedite approval pathways for non-opioid devices and drugs to control pain and prevent further addictions. Other opioid bills passed by the House subpanel seek to remove reimbursement challenges for opioid-alternative pain control devices.

Capitol House

As part of an overall effort by the US Congress to stop the ongoing opioid epidemic, a key Senate Committee and House subcommittee approved bills this week to expedite approval of non-addictive devices and drugs that could serve as alternatives to opioids for control of acute and chronic pain.

On April 24, the Senate HELP Committee passed the “Opioid Crisis Response Act of 2018,” onto the full Senate. A...

Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

More from Legislation

More from Policy & Regulation